Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus.

The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...

Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating ...

The projected fair value for Henry Schein is US$67.04 based on 2 Stage Free Cash Flow to Equity With US$70.70 share price, Henry Schein appears to be trading close to its estimated fair value ...

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

Dental and medical professionals who may experience operational, logistical, or financial issues are encouraged to call 800-999-9729 ...

Henry Schein is launching a relief fund to provide essential medical supplies to support victims of the Los Angeles wildfires. The company is committing up to $300,000, including $150,000 in cash and ...

Fintel reports that on January 6, 2025, B of A Securities upgraded their outlook for Henry Schein (NasdaqGS:HSIC) from ...

BofA upgraded Henry Schein (HSIC) to Buy from Underperform with an $84 price target Don't Miss Our New Year's Offers:Discover the latest stocks ...

BofA sees 2025 challenges for healthcare tech and distributors but upgrades Cardinal Health and Henry Schein, highlighting ...